What one share of Ionis Pharmaceuticals holds
For three decades, we have invented medicines that bring better futures to people with serious diseases. As a pioneer in RNA-targeted medicines with a deep understanding of disease biology and an industry-leading drug discovery technology, we are driven to deliver innovative, life-changing advances for patients.
Ionis Pharmaceuticals’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $5.36 |
|---|---|
| Profit | −$3.47 |
| Capex (buildings and equipment) | $0.39 |
| Free cash flow | −$3.44 |
| Cash and investments | $2.11 |
| Debt | $10.63 |
| Book value | $2.65 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2008 | $1.13 | −$0.19 | $0.14 | $2.10 | — | $1.56 |
| 2009 | $1.24 | $1.58 | $0.14 | −$1.24 | — | $2.95 |
| 2010 | $1.09 | −$0.62 | $0.13 | −$0.77 | — | $2.46 |
| 2011 | $0.99 | −$0.85 | $0.10 | −$1.25 | — | $1.71 |
| 2012 | $1.01 | −$0.65 | $0.01 | $0.00 | — | $1.80 |
| 2013 | $1.33 | −$0.55 | $0.01 | $0.56 | — | $3.25 |
| 2014 | $1.82 | −$0.33 | $0.06 | −$0.01 | — | $2.18 |
| 2015 | $2.37 | −$0.74 | $0.06 | $0.11 | — | $1.67 |
| 2016 | $2.87 | −$0.50 | $0.06 | −$0.99 | — | $0.82 |
| 2017 | $4.03 | $0.15 | $0.28 | $1.11 | — | $2.25 |
| 2018 | $4.47 | $2.07 | $0.10 | $4.40 | — | $7.60 |
| 2019 | $7.33 | $1.90 | $0.20 | $2.05 | — | $10.48 |
| 2020 | $5.22 | −$3.18 | $0.25 | $0.01 | — | $5.30 |
| 2021 | $5.75 | −$0.20 | $0.08 | $0.13 | — | $5.47 |
| 2022 | $4.14 | −$1.90 | $0.11 | −$2.05 | — | $4.03 |
| 2023 | $5.50 | −$2.56 | $0.17 | −$2.31 | — | $2.68 |
| 2024 | $4.72 | −$3.04 | $0.30 | −$3.65 | — | $3.73 |
| 2025 | $5.90 | −$2.38 | $0.32 | −$2.00 | — | $2.99 |
Common questions about Ionis Pharmaceuticals
How much does one share of Ionis Pharmaceuticals earn?
Over the last 12 months, Ionis Pharmaceuticals lost $3.47 for each share on $5.36 of sales.
Does Ionis Pharmaceuticals pay a dividend?
Ionis Pharmaceuticals didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Ionis Pharmaceuticals’s book value per share?
Ionis Pharmaceuticals’s book value is $2.65 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Ionis Pharmaceuticals have?
Each share of Ionis Pharmaceuticals has $2.11 of cash and investments and $10.63 of debt, as of June 30, 2026.
What is Ionis Pharmaceuticals’s free cash flow per share?
−$3.44 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Ionis Pharmaceuticals bought back shares?
Ionis Pharmaceuticals’s share count rose about 69% from 2008 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.